Core One Labs Akome Biotech Protects New AK003 Ketamine-Based Breakthrough Drug Formulation for Depression Treatment sharewise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharewise.com Daily Mail and Mail on Sunday newspapers.
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“
Core One” or the “
Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc. (“
Vocan”) will be presenting at a Company hosted Virtual Town Hall meeting on Wednesday, August 4, 2021 at 1:30 p.m. PST/ 4:30 p.m. ET/ 22:30 p.m. CET.
The Virtual Town Hall event will comprise of a presentation by Dr. Hancock on the status of Vocan’s production of biosynthetic psilocybin and will include live video from the Company’s operating laboratory in Victoria, British Columbia. Dr. Hancock will also be answering questions from investors.
Ad-hoc am Sonntag: Hochexplosiver Cocktail! - Wieder überproportionale Gewinne zu Wochenbeginn? finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is…
Dutch consulate event supports e-commerce development in Kurdistan Region kurdistan24.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurdistan24.net Daily Mail and Mail on Sunday newspapers.